We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £211,595
Drop Bear Beer Co. is a specialist brewer of less than 0.5% craft beers. The company asserts that its products are vegan, gluten-free, and low in calories. It has brewed over 160,000 bottles to date. Drop Bear argues that the Global Non-Alcoholic Drinks market was valued at $18 billion in 2020. It aims to be a significant contender in the segment. The company's products are available in six global markets. Drop Bear has won awards ranging from a World Beer Award to a Great British Entrepreneur Award. The company will use the investment to expand its team and build a second dedicated alcohol-free brewery in the UK.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £325,000
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £270,543
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £200,000
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,048,396
HUUB is a premium endurance sports apparel brand. Its products are used by Olympic gold medallists, 'IRONMAN' champions and amateur athletes. HUUB witnessed profits worth £4.8 million and an EBITDA of £420,000 in 2019. The company is a leading brand in the £60 million UK triathlon apparel & accessories market. HUBB is now targeting the US$5 billion global bike apparel market. It has built working relationships with noteworthy individuals such as former Olympian Greg Whyte and chef Gordon Ramsay. The company will use the investment to target all endurance sports through a combination of retail and distributor partnerships. It will also expand its Direct-To-Consumer (DTC) online business.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,352,941
West Berkshire Brewery is a beer manufacturer on a mission to deliver best-in-class beers, from heritage styles to modern craft beers, to its customers. Its products are on the shelves of UK supermarkets including Waitrose, Tesco and the Co-Op. The company can scale up to 26 million pints per annum thanks to its modern brewery units that are equipped with bottling and canning lines technologies along with the option of cold storage. Its brewery consists of a 200-capacity 'Taproom & Kitchen', a destination venue that generates a revenue of £1.4 million per annum. It will utilise the investment to support the installation and commissioning of its 'Fridge Pack Machine', support marketing initiatives with its pub partners across the South of England, and provide capital to enable any pub acquisition opportunities as they arise over the coming year.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,390,948
Mami Wata (MW) is a purpose-led, premium African surf lifestyle brand on a mission to redefine the global surf market. MW asserts that it has collaborated with global luxury brand, Moncler, and partnered with renowned stockists including Mr Porter and Huckberry. It aims to be a contender in the $9 billion global surfing market. It has also shipped 1200+ copies of its AFROSURF art book to 39 countries along with funding a surf therapy clubhouse in Harper, Liberia. MW has sold products to 7,500+ customers generating more than £400,000 in revenue to date. The company has featured in global media entities such as CNN, GQ, Wallpaper, Monocle, and HypeBeast. MW will use the investment for its international launch in the USA.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,145,799
Ring Powercraft is a designer and manufacturer of sports boats and rigid-hull inflatable boats (RHIBs). The company's product offerings is backed by robust infrastructure, practical design elements, and a naval architecture team, all of which, are leveraged to produce sales across the commercial, leisure, adventure and defence sectors. In 2018, the company celebrated its 50th anniversary. The company has, under Cetus Holdings Limited since 2019, ventured into securing defence contracts. It has also tied up with marine exploration company, Arksen, to create adventure vessels since January 2020. The company is seeking investment to procure tenders for various users such as the ministry of defence, police forces, and the United Nations.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £202,818
Bazar is the UK’s first dedicated ethical marketplace and lifestyle application. The company intends to disrupt the ~£32.8 billion UK consumer marketplace by creating a platform where eco-friendly businesses can thrive, and consumers can trust brand values. It brings curated ethical and eco-friendly brands, artisans, and items under one portal. BAZAR soft-launched its application with 35 sellers and 650 products in the COVID-19 lockdown which doubled showing positive seller demand. The app saw over 1800 downloads with early sales. The company has a social media presence with over 1500+ Instagram followers. It intends to enter the US market in 2022, followed by Europe. Bazar will use the investment to continue to develop its technology to help sellers grow their business and give buyers an intuitive shopping experience on the app. 

Pitch Rated

49%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £208,368
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph